DE69523074D1 - Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung - Google Patents

Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung

Info

Publication number
DE69523074D1
DE69523074D1 DE69523074T DE69523074T DE69523074D1 DE 69523074 D1 DE69523074 D1 DE 69523074D1 DE 69523074 T DE69523074 T DE 69523074T DE 69523074 T DE69523074 T DE 69523074T DE 69523074 D1 DE69523074 D1 DE 69523074D1
Authority
DE
Germany
Prior art keywords
biological tissues
implantable biological
reduce calcification
treating implantable
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523074T
Other languages
English (en)
Other versions
DE69523074T2 (de
Inventor
Sophie Carpentier
Alain Carpentier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Application granted granted Critical
Publication of DE69523074D1 publication Critical patent/DE69523074D1/de
Publication of DE69523074T2 publication Critical patent/DE69523074T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69523074T 1994-07-29 1995-07-25 Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung Expired - Lifetime DE69523074T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28235894A 1994-07-29 1994-07-29
PCT/US1995/010001 WO1996004028A1 (en) 1994-07-29 1995-07-25 Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods

Publications (2)

Publication Number Publication Date
DE69523074D1 true DE69523074D1 (de) 2001-11-08
DE69523074T2 DE69523074T2 (de) 2002-06-06

Family

ID=23081148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523074T Expired - Lifetime DE69523074T2 (de) 1994-07-29 1995-07-25 Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung

Country Status (6)

Country Link
US (2) US6561970B1 (de)
EP (1) EP0804255B1 (de)
JP (1) JP3797673B2 (de)
CA (1) CA2196165C (de)
DE (1) DE69523074T2 (de)
WO (1) WO1996004028A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40570E1 (en) 1994-07-29 2008-11-11 Edwards Lifesciences Corporation Apparatuses and methods for treating biological tissue to mitigate calcification
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
EP0804255B1 (de) 1994-07-29 2001-10-04 Edwards Lifesciences Corporation Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US5782931A (en) * 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
EP1378257B1 (de) * 1996-08-23 2008-05-14 Cook Biotech, Inc. Transplantationsprothese auf Kollagenbasis
US8716227B2 (en) * 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6214054B1 (en) * 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6440164B1 (en) * 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US7377938B2 (en) * 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
US20030022146A1 (en) * 2001-07-26 2003-01-30 Cunanan Crystal M. Oxidized bioprosthetic materials
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US7007698B2 (en) * 2002-04-03 2006-03-07 Boston Scientific Corporation Body lumen closure
US6752828B2 (en) * 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US8349348B2 (en) * 2002-08-06 2013-01-08 Matrix Medical, Llc Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
US9101536B2 (en) * 2002-08-06 2015-08-11 Matrix Medical Llc Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
EP3915529A1 (de) * 2002-08-06 2021-12-01 BAXTER INTERNATIONAL INC. (a Delaware corporation) Biokompatible phasenumkehrbare proteinhaltige zusammensetzungen und verfahren zur herstellung und verwendung davon
US10098981B2 (en) 2002-08-06 2018-10-16 Baxter International Inc. Biocompatible phase invertable proteinaceous compositions and methods for making and using the same
WO2004037128A1 (en) * 2002-10-24 2004-05-06 Boston Scientific Limited Venous valve apparatus and method
US7189259B2 (en) * 2002-11-26 2007-03-13 Clemson University Tissue material and process for bioprosthesis
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
US6945957B2 (en) * 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US7474722B1 (en) * 2003-03-21 2009-01-06 D2Audio Corporation Systems and methods for sample rate conversion using multiple rate estimate counters
US7330999B2 (en) * 2003-04-23 2008-02-12 Dot Hill Systems Corporation Network storage appliance with integrated redundant servers and storage controllers
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7854761B2 (en) * 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) * 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7878966B2 (en) * 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7780722B2 (en) * 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7670368B2 (en) * 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US20060195183A1 (en) * 2005-02-18 2006-08-31 The Cleveland Clinic Foundation Apparatus and methods for replacing a cardiac valve
US7867274B2 (en) * 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7579381B2 (en) * 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
WO2006113906A1 (en) * 2005-04-20 2006-10-26 The Cleveland Clinic Foundation Apparatus and method for replacing a cardiac valve
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US7569071B2 (en) * 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7658706B2 (en) * 2005-12-05 2010-02-09 Rti Biologics, Inc. Vascular graft sterilization and decellularization
US7799038B2 (en) * 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
WO2008002767A1 (en) * 2006-06-29 2008-01-03 Mayo Foundation For Medical Education And Research Genetically modified heart valve xenografts
CN103933612B (zh) * 2006-10-27 2016-06-22 爱德华兹生命科学公司 用于外科植入的生物组织
US8142805B1 (en) 2006-11-06 2012-03-27 Clemson University Research Foundation Implantable devices including fixed tissues
WO2008091493A1 (en) 2007-01-08 2008-07-31 California Institute Of Technology In-situ formation of a valve
WO2008089365A2 (en) * 2007-01-19 2008-07-24 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US7967853B2 (en) 2007-02-05 2011-06-28 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
EP2117468A1 (de) * 2007-02-05 2009-11-18 Boston Scientific Limited Systeme und verfahren zur herzklappenfreisetzung
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
WO2008154532A1 (en) * 2007-06-11 2008-12-18 California Pacific Medical Center Method and kit for dynamic gene expression monitoring
US8828079B2 (en) * 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US20090171456A1 (en) * 2007-12-28 2009-07-02 Kveen Graig L Percutaneous heart valve, system, and method
US9119714B2 (en) * 2008-10-29 2015-09-01 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer prosthetic medical device
US20100261662A1 (en) * 2009-04-09 2010-10-14 Endologix, Inc. Utilization of mural thrombus for local drug delivery into vascular tissue
WO2010127041A1 (en) * 2009-04-29 2010-11-04 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
WO2011002996A2 (en) * 2009-07-02 2011-01-06 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
FR2951549B1 (fr) 2009-10-15 2013-08-23 Olivier Schussler Procede d'obtention de bioprotheses medicales implantables
US9211361B2 (en) * 2010-03-15 2015-12-15 Kemal Schankereli Thin collagen tissue for medical device applications
BR122014006918B1 (pt) 2010-03-23 2020-09-29 Edwards Lifesciences Corporation. Método para preparar material de membrana de tecido bioprotético
WO2011139488A2 (en) 2010-05-06 2011-11-10 Mayo Foundation For Medical Education And Research Methods and materials for reducing cardiac xenograft rejection
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
CA2794135C (en) 2010-06-17 2018-01-02 Edwards Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US9358107B2 (en) 2011-06-30 2016-06-07 Edwards Lifesciences Corporation Systems, dies, and methods for processing pericardial tissue
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
CN102499993B (zh) * 2011-11-01 2014-01-15 上海微创医疗器械（集团）有限公司 一种边缘刚性化人工生物瓣膜的制备方法
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
WO2014144247A1 (en) 2013-03-15 2014-09-18 Arash Kheradvar Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
US10631968B2 (en) 2017-03-06 2020-04-28 Edwards Lifesciences Corporation Humidity-management packaging systems and methods
WO2018222434A1 (en) 2017-05-31 2018-12-06 Edwards Lifesciences Corporation Collagen fibers and articles formed therefrom
WO2019147585A1 (en) 2018-01-23 2019-08-01 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
US11103619B2 (en) 2018-08-30 2021-08-31 Efstathios-Andreas AGATHOS Anticalcification treatment for impantable biological tissues using calcitonin
WO2020092205A1 (en) 2018-11-01 2020-05-07 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve
EP3920849A1 (de) 2019-02-04 2021-12-15 Medtronic, Inc. Ballonexpandierbarer rahmen zur transkatheterimplantation einer herzklappenprothese
US11771554B2 (en) 2019-05-17 2023-10-03 Medtronic, Inc. Supra annular tapered balloon expandable stent for transcatheter implantation of a cardiac valve prosthesis
CR20220339A (es) 2019-12-12 2022-11-09 Edwards Lifesciences Corp Anillo de anuloplastia híbrido
CN111588909A (zh) * 2020-02-24 2020-08-28 科凯(南通)生命科学有限公司 一种生物医用材料防钙化的方法
US12011349B2 (en) 2020-03-04 2024-06-18 Medtronic, Inc. Balloon expandable stent with lengthened commissure posts for transcatheter implantation of a cardiac valve prosthesis
US12083009B2 (en) 2020-04-15 2024-09-10 Vitae LLC Method of processing collagen-based tissue for bioprosthetic devices
CN115350332A (zh) * 2022-09-01 2022-11-18 晨兴(南通)医疗器械有限公司 抗钙化生物瓣膜材料的制备方法及抗钙化生物瓣膜材料

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2393580A (en) 1942-03-31 1946-01-22 Edwin C Weiskopf Method of preparing tissue
DE1063330B (de) 1955-11-01 1959-08-13 Dr Med Norman Rosenberg Stoffe fuer Fremdtransplantationen
US3093439A (en) 1961-07-05 1963-06-11 Johnson & Johnson Process for preparing tanned collagenous material with dialdehyde starch
US3961097A (en) 1971-10-28 1976-06-01 Gravlee Jr Joseph F Method of preparing tissue for microscopic examination
US4050893A (en) 1974-07-22 1977-09-27 Hancock Laboratories, Inc. Arrangement for preparing natural tissue for implantation
IL47062A (en) 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4082507A (en) 1976-05-10 1978-04-04 Sawyer Philip Nicholas Prosthesis and method for making the same
US4239492A (en) 1979-06-14 1980-12-16 Beisang Arthur A Method of preparing vascular grafts of human and other umbilical cord origins for tissue ingrowth
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
DE3042860A1 (de) 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
IN157379B (de) 1981-04-30 1986-03-15 Extracorporeal Med Spec
US4323358A (en) 1981-04-30 1982-04-06 Vascor, Inc. Method for inhibiting mineralization of natural tissue during implantation
US4350492A (en) 1981-08-24 1982-09-21 Vascor, Inc. Method for preparing tissue heart valve
FR2523810B1 (fr) 1982-03-23 1988-11-25 Carpentier Alain Tissu biologique greffable et procede pour sa preparation
US4481009A (en) * 1982-05-13 1984-11-06 American Hospital Supply Corporation Polymer incorporation into implantable biological tissue to inhibit calcification
US4402697A (en) * 1982-08-25 1983-09-06 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
US4405327A (en) 1982-08-25 1983-09-20 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
JPS60500014A (ja) * 1982-11-12 1985-01-10 バツクスター　トラベノル　ラボラトリーズ　インコーポレーテツド 移殖できる生物学的組織の化学滅菌
US5215541A (en) * 1982-11-12 1993-06-01 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
WO1984001879A1 (en) 1982-11-12 1984-05-24 American Hospital Supply Corp Surfactant treatment of implantable biological tissue to inhibit calcification
US4885005A (en) 1982-11-12 1989-12-05 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US4713446A (en) * 1985-09-06 1987-12-15 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for ophthalmic use and method of preparation
US4729139A (en) * 1985-11-05 1988-03-08 Baxter Travenol Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
US4770665A (en) * 1985-11-05 1988-09-13 American Hospital Supply Corporation Elastomeric polymer incorporation into implantable biological tissue to inhibit calcification
US4786287A (en) 1986-10-10 1988-11-22 Baxter Travenol Laboratories Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
US4798611A (en) * 1986-10-14 1989-01-17 Hancock Jaffe Laboratories Enhancement of xenogeneic tissue
US4800603A (en) * 1987-01-30 1989-01-31 Jaffe Norman R Tissue fixation with vapor
US4994237A (en) * 1987-10-02 1991-02-19 The Beth Israel Hospital Association Microwave preservation of bioprostheses
EP0364517B1 (de) 1988-02-03 1994-04-06 Biomedical Design, Inc. Verhütung der kalzifizierung einer prothese
US4976733A (en) 1988-02-03 1990-12-11 Biomedical Design, Inc. Prevention of prosthesis calcification
US5746775A (en) 1988-04-01 1998-05-05 The Board Of Regent6S Of The University Of Michigan Method of making calcification-resistant bioprosthetic tissue
EP0362438A1 (de) 1988-06-21 1990-04-11 Mathilde Elisabeth Boon Mikrowellenbehandlung von xenogenen Knorpeltransplantaten
SU1651890A1 (ru) * 1988-06-22 1991-05-30 Институт сердечно-сосудистой хирургии им.А.Н.Бакулева Способ обработки биопротезов клапанов сердца
US5264214A (en) * 1988-11-21 1993-11-23 Collagen Corporation Composition for bone repair
US5171273A (en) * 1989-01-13 1992-12-15 University Of Medicine And Dentistry Of New Jersey Synthetic collagen orthopaedic structures such as grafts, tendons and other structures
US5002566A (en) 1989-02-17 1991-03-26 Baxter International Inc. Calcification mitigation of bioprosthetic implants
US5068086A (en) 1990-06-12 1991-11-26 Raytheon Company Method and apparatus for batch fixating tissue specimens
US5104405A (en) 1991-02-21 1992-04-14 The University Of Southern California Process for improving the biostability of tissue implant devices and bioprosthetic implants so produced
US5476516A (en) * 1992-03-13 1995-12-19 Albert Einstein College Of Medicine Of Yeshiva University Anticalcification treatment for aldehyde-tanned biological tissue
US5283256A (en) * 1992-07-22 1994-02-01 Merck & Co., Inc. Cholesterol-lowering agents
US5437287A (en) * 1992-08-17 1995-08-01 Carbomedics, Inc. Sterilization of tissue implants using iodine
US5447536A (en) * 1994-02-17 1995-09-05 Biomedical Design, Inc. Method for fixation of biological tissue
JPH09510108A (ja) 1994-03-14 1997-10-14 クリオライフ，インコーポレイティド 移植用処理組織及び調製方法
US5595571A (en) 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
EP0804255B1 (de) 1994-07-29 2001-10-04 Edwards Lifesciences Corporation Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
US5674298A (en) * 1994-10-21 1997-10-07 The Board Of Regents Of The University Of Michigan Calcification-resistant bioprosthetic tissue and methods of making same
US5782931A (en) * 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
AU735988B2 (en) * 1997-02-10 2001-07-26 Biomedical Design, Inc. Method of sterilization
US5891196A (en) * 1997-04-16 1999-04-06 Baxter International Inc. Method for actively binding heparin to crosslinked biological tissues
US6008292A (en) * 1997-12-02 1999-12-28 Baxter International Inc. Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials
BE1012763A3 (nl) 1999-06-25 2001-03-06 Wiele Michel Van De Nv Poolgaren selectiesysteem voor grijperaxminsterweefmachines.

Also Published As

Publication number Publication date
WO1996004028A1 (en) 1996-02-15
US6561970B1 (en) 2003-05-13
JP3797673B2 (ja) 2006-07-19
EP0804255A1 (de) 1997-11-05
US7029434B2 (en) 2006-04-18
DE69523074T2 (de) 2002-06-06
CA2196165A1 (en) 1996-02-15
EP0804255B1 (de) 2001-10-04
CA2196165C (en) 2004-06-08
US20040030405A1 (en) 2004-02-12
JPH10507102A (ja) 1998-07-14

Similar Documents

Publication Publication Date Title
DE69523074D1 (de) Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69806970D1 (de) Verfahren zur behandlung von hartgeweben
DE69925266D1 (de) Verfahren und gerät zur behandlung von herzarhythmie
DE69829336D1 (de) Vorrichtung und Verfahren zur Behandlung von Körpergewebe
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69821913D1 (de) Verfahren zur behandlung der hautpigmentierung
DE60042611D1 (de) Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
DE69434672D1 (de) Verfahren zur behandlung von hühnereiern
DE69421912D1 (de) Methode zur behandlung von wasser
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE60029033D1 (de) Verfahren zur Behandlung von Tissuepapier
DE69714828D1 (de) Verfahren zur Behandlung von Abfallstoffen
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69427774D1 (de) Kontinuierliches verfahren zur behandlung von nahrungsmitteln
ATE257189T1 (de) Verfahren zur behandlung von cellulosischen formkörpern
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
DE69626311D1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69328615D1 (de) Verfahren zur behandlung von viehhaltungsgülle
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE59102745D1 (de) Verfahren une einrichtung zur behandlung von saatgut.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition